<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/elvn" ></link>
<id>urn:uuid:42be4a58-966d-1580-38fc-1872d4cb779f</id>
<updated>2026-09-17T06:14:18-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>ELVN: HOHL BENJAMIN (CFO) Sold (AS) 6,018 Shares of ENLIVEN THERAPEUTICS INC for $58.35-$59.35 on 8/17</title>
<link href="http://www.insiderinsights.com/company/elvn/enliven-therapeutics-inc/id-6456980" ></link>
<id>urn:uuid:ec3979e1-c966-14f8-90e8-b43819537c4f</id>
<updated>2026-08-19T16:17:49-04:00</updated>
<summary type="html" ><![CDATA[ENLIVEN THERAPEUTICS INC (ELVN). Recent Price: $54.32. Mkt Cap:4.0B. 10D Vol: 953,790]]></summary>
</entry>
<entry>
<title>ELVN: COLLINS HELEN LOUISE (O) Exercised 5k Options (OE) of ENLIVEN THERAPEUTICS INC for $2.48 on 8/17, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/elvn/enliven-therapeutics-inc/id-6456961" ></link>
<id>urn:uuid:31234ea6-978b-29a9-0c4b-e382c7c88f60</id>
<updated>2026-08-19T16:16:13-04:00</updated>
<summary type="html" ><![CDATA[ENLIVEN THERAPEUTICS INC (ELVN). Recent Price: $54.32. Mkt Cap:4.0B. 10D Vol: 953,790]]></summary>
</entry>
<entry>
<title>ELVN: DERYNCK MIKA K (DIR) Exercised 158,795 Options (OE) of ENLIVEN THERAPEUTICS INC for $2.48-$22.47 on 8/4, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/elvn/enliven-therapeutics-inc/id-6450390" ></link>
<id>urn:uuid:855548be-a0ef-3d03-8e13-adcc6ef292fb</id>
<updated>2026-08-06T20:18:03-04:00</updated>
<summary type="html" ><![CDATA[ENLIVEN THERAPEUTICS INC (ELVN). Recent Price: $54.32. Mkt Cap:4.0B. 10D Vol: 953,790]]></summary>
</entry>
<entry>
<title>ELVN: HOHL BENJAMIN (CFO) Exercised 1,072 Options (OE) of ENLIVEN THERAPEUTICS INC for $2.48 on 7/17, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/elvn/enliven-therapeutics-inc/id-6443785" ></link>
<id>urn:uuid:d513adcf-68ca-9910-20c0-29d738c10015</id>
<updated>2026-07-21T17:24:30-04:00</updated>
<summary type="html" ><![CDATA[ENLIVEN THERAPEUTICS INC (ELVN). Recent Price: $54.32. Mkt Cap:4.0B. 10D Vol: 953,790]]></summary>
</entry>
<entry>
<title>ELVN: COLLINS HELEN LOUISE (O) Exercised 5k Options (OE) of ENLIVEN THERAPEUTICS INC for $2.48 on 7/17, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/elvn/enliven-therapeutics-inc/id-6443783" ></link>
<id>urn:uuid:acf55911-4d7f-3a11-5287-d46ac18a0dee</id>
<updated>2026-07-21T17:23:03-04:00</updated>
<summary type="html" ><![CDATA[ENLIVEN THERAPEUTICS INC (ELVN). Recent Price: $54.32. Mkt Cap:4.0B. 10D Vol: 953,790]]></summary>
</entry>
<entry>
<title>ELVN: KUNKEL LORI ANNE (DIR) Sold (AS) 10k Shares of ENLIVEN THERAPEUTICS INC for $49.98-$50.84 on 7/6</title>
<link href="http://www.insiderinsights.com/company/elvn/enliven-therapeutics-inc/id-6439693" ></link>
<id>urn:uuid:19a16795-61cc-50c2-8298-117151029f41</id>
<updated>2026-07-08T17:15:48-04:00</updated>
<summary type="html" ><![CDATA[ENLIVEN THERAPEUTICS INC (ELVN). Recent Price: $54.32. Mkt Cap:4.0B. 10D Vol: 953,790]]></summary>
</entry>
</feed>